Search | Syneos Health Communications

#1

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#2

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

#3

With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.

#4

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#5

Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”

#6

COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.

#7

Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.

#8

As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.

#9

As we continue to navigate these unprecedented times, Syneos Health conducted two surveys during the months of March and May to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.

#10

In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.

#11

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#12

With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.

#13

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#14

Virtual delivery requires you to rethink your content and approaches.

#15

Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.

#16

In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.

#17

Life sciences companies have a variety of tools to demonstrate the value of their medicines in the real world, but any innovative agreement or study should definitively answer these five questions.

#18

How are payers responding to COVID-19?

#19

Think Bank is an agile way to answer complex questions.

#20

To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.

#21

Recommendations for activities to inform and engage

#22

In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.

#23

In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."

#24

At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.

#25

You might want to think twice about ignoring that call from a random number.

#26

Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.

#27

As the pandemic surged, New York City’s Mt.

#28

Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19.

#29

The Food and Drug Administration (FDA) has approved the use of Veklury (remdesivir) for use in adult and adolescent patients 12 years of age and older for the treatment of COVID-19 in instances that require hospitalization.

#30

The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.

Search Results

Connect

Site

Search Results

Connect

Site

Subscribe to our RSS feed